Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

A Novel Protease-Mediated Chimeric Antigen Receptor (CAR): "Double-Arm" CAR-T Cell System Improves Target Specificity of CAR-T Cell Therapy

Satoru Aoyama, MD, Shunichiro Yasuda, MD, Daisuke Watanabe, MD, Hiroki Akiyama, MD, PhD, Yoshihiro Umezawa, MD, PhD, Ayako Nogami, MD PhD BPharm, Osamu Miura, MD, PhD, Norihiko Kawamata, MD, PhD

Blood (2019) 134 (Supplement_1): 1941.

https://doi.org/10.1182/blood-2019-121973

Published: 2019

Journal Articles

Genomic and Pathway Connectivity Analyses Identify Novel Strategies to Overcome mTOR Inhibitor Resistance In DLBCL

Adam M. Petrich, MD, Violetta V. Leshchenko, PhD, Pei-Yu Kuo, MS, B. Hilda Ye, PhD, Joseph A Sparano, MD, Samir Parekh, MD

Blood (2010) 116 (21): 436.

https://doi.org/10.1182/blood.V116.21.436.436

Published: 2010

Journal Articles

The HIV Protease Inhibitor Nelfinavir: A Unique Oral Drug That Inhibits the Proteasome and AKT-Phosphorylation, Induces ER Stress and Sensitizes Bortezomib-Refractory Primary Myeloma Cells and Primary AML Cells towards Bortezomib

Christoph Driessen, MD, Jürgen Bader, Marianne Kraus

Blood (2010) 116 (21): 4069.

https://doi.org/10.1182/blood.V116.21.4069.4069

Published: 2010

Journal Articles

Inhibition of Autophagy Promotes Bortezomib-Mediated Cell Death in Myeloma Cells

Terry H. Landowski, PhD, Aluvia M Escalante, Andrew Jefferson, Robert T Dorr, Ronald Lynch

Blood (2008) 112 (11): 3677.

https://doi.org/10.1182/blood.V112.11.3677.3677

Published: 2008

Journal Articles

Saquinavir Inhibits Proliferation and Promotes Apoptosis in Imatinib-Resistant Chronic Myelogenous Leukemia Lines and Inhibits CFU-GM Growth in CML Blastic Crisis.

Fabio S. Timeus, MD, PhD, Nicoletta Crescenzio, BSc, Alessandra Doria, BSc, Luiselda C. Foglia, BSc, Daniele Bertin, MD, Giuseppe Saglio, MD, Pier Angelo Tovo, MD

Blood (2005) 106 (11): 4846.

https://doi.org/10.1182/blood.V106.11.4846.4846

Published: 2005

Journal Articles

Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss

Barbara N. Phenix, Julian J. Lum, Zelin Nie, Jaime Sanchez-Dardon, Andrew D. Badley

Blood (2001) 98 (4): 1078–1085.

https://doi.org/10.1182/blood.V98.4.1078

Published: 2001

Journal Articles

HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells

Takayuki Ikezoe, Eric S. Daar, Jun-ichi Hisatake, Hirokuni Taguchi, H. Phillip Koeffler

Blood (2000) 96 (10): 3553–3559.

https://doi.org/10.1182/blood.V96.10.3553

Published: 2000

Journal Articles

HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression–independent mechanism

Wei Lu, Jean-Marie Andrieu

Blood (2000) 96 (1): 250–258.

https://doi.org/10.1182/blood.V96.1.250

Published: 2000

NARROW

A Novel Protease-Mediated Chimeric Antigen Receptor (CAR): "Double-Arm" CAR-T Cell System Improves Target Specificity of CAR-T Cell Therapy

Genomic and Pathway Connectivity Analyses Identify Novel Strategies to Overcome mTOR Inhibitor Resistance In DLBCL

The HIV Protease Inhibitor Nelfinavir: A Unique Oral Drug That Inhibits the Proteasome and AKT-Phosphorylation, Induces ER Stress and Sensitizes Bortezomib-Refractory Primary Myeloma Cells and Primary AML Cells towards Bortezomib

Inhibition of Autophagy Promotes Bortezomib-Mediated Cell Death in Myeloma Cells

Saquinavir Inhibits Proliferation and Promotes Apoptosis in Imatinib-Resistant Chronic Myelogenous Leukemia Lines and Inhibits CFU-GM Growth in CML Blastic Crisis.

Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss

HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells

HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression–independent mechanism

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only